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PERSPECTIVE
Ingested asbestos in ﬁltered beer, in addition to occupational
exposure, as a causative factor in oesophageal adenocarcinoma
Rebecca C. Fitzgerald1 and Jonathan M. Rhodes2
Oesophageal adenocarcinoma has become much more common over the past 50 years, particularly in Britain, with an unexplained
male to female ratio of > 4:1. Given the use of asbestos ﬁltration in commercial brewing and reports of its unregulated use in British
public houses in the 1970’s to clear draught beer “slops”, we have assessed the hypothesis that ingested asbestos could be a
causative factor for this increased incidence. Importantly, occupational asbestos exposure increases the risk of adenocarcinoma but
not squamous cell carcinoma of the oesophagus. The presence of asbestos ﬁbres was consistently reported in ﬁltered beverages
including beers in the 1970s and asbestos bodies have been found in gastrointestinal tissue, particularly oesophageal tissue, at
autopsy. There is no reported association between the intake of alcohol and oesophageal adenocarcinoma but studies would
mostly have missed exposure from draught beer before 1980. Oesophageal adenocarcinoma has some molecular similarities to
pleural mesothelioma, a condition that is largely due to inhalation of asbestos ﬁbres, including predominant loss of tumour
suppressor genes rather than an increase of classical oncogenic drivers. Trends in incidence of oesophageal adenocarcinoma and
mesothelioma are similar, rising rapidly over the past 50 years but now plateauing. Asbestos ingestion, either from beer consumed
before around 1980, or from occupational exposure, seems a plausible causative factor for oesophageal adenocarcinoma. If this is
indeed the case, its incidence should fall back to a low baseline by around 2050.
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BACKGROUND
There has been a dramatic increase, approximately six-fold, in the
incidence of oesophageal adenocarcinoma over the past 50
years,1 but with a very uneven geographical distribution and a
striking male predominance. Oesophageal adenocarcinoma has
become much more common in northern and western Europe,
North America, and Oceania than in other parts of the world.2
Large differences also exist between western European countries,
with incidence rates (per 100,000 men) in the UK (6.33 in 2005)
and the Netherlands (5.32) that far exceed those in other
European countries including Denmark (2.80), France (1.87), Spain
(1.29) Slovakia (0.81), Italy (0.76), and Croatia (0.60).3 The very
marked male predominance−up to 9:1 male-to-female ratio−is
also unexplained.4 Increasing rates of obesity and the decline in
Helicobacter pylori gastritis, with its possible consequential
increase in acidity of reﬂuxate, can only offer partial explanations
for the increased incidence. The pre-malignant condition, Barrett’s
oesophagus, in which intestinal metaplasia affects a variable
length of the lower oesophagus, changing it from a squamous to a
columnar epithelium, is strongly associated with gastro-
oesophageal reﬂux. Reﬂux in turn is strongly associated with risk
for oesophageal adenocarcinoma but modelling has estimated
that other factors account for 78% of the increasing incidence in
men and 33% of the increase in women.5 Barrett’s oesophagus
also shows a male predominance, but this is much less marked
with an overall risk ratio of just under 2:1.4
The increase has not impacted equally on all ages, suggesting a
possible cohort effect.6 Thus, in England where the incidence of
adenocarcinoma rose more than three-fold between 1972 and
2012, incidence rates per 100,000 for men aged 40–49 years only
increased from 1.7 to 3.1 whereas rates for those 80 years and
above increased from 23.0 to 84.1.7 Moreover, the overall
incidence of oesophageal adenocarcinoma has been levelling
off since ~2010 8 and possibly even starting to fall in countries
with a high incidence such as England7 and Denmark.3 In this
article we review the possibility that ingestion of asbestos, used
as a ﬁltering agent in alcoholic drinks, particularly beers, up to the
late 1970s might be a causative factor for oesophageal
adenocarcinoma.
ASBESTOS FILTERING OF BEERS AND OTHER ALCOHOLIC
DRINKS
Asbestos ﬁltering has in the past been used routinely in the
alcoholic drinks industry to clear sediments and microorganisms
from beer and other drinks prior to bottling.9 This procedure has a
long history - thus, from 1914: “To be successful in chilled beer
bottling the ﬁlters and the pulp are of the ﬁrst importance…. best
beer asbestos should be added once a week at the rate of 8oz. per
cwt. of pulp being washed …care must be taken not to add too
much asbestos, otherwise clogging of the ﬁlter plates ensues. The
asbestos should always be whisked up to a cream with water and
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added slowly to the circulating pulp.10” While we cannot be sure
which type of asbestos was used for beer ﬁltration, the
widespread use of chrysotile in the wine ﬁltration industry makes
this the most likely candidate for beer ﬁltration (Box 1).
Furthermore, an electron microscopy study of ashed centrifugates
from six samples of commercially bottled and canned beers,
published in 1968, revealed what were thought to be chrysotile
asbestos ﬁbres at an average of around 5000 ﬁbres per pint.11 A
subsequent study showed even higher concentrations of asbestos
ﬁbre in beer but with still higher concentrations in some samples
of ﬁltered public tap water supplies in Canadian cities.12 Various
anecdotal sources suggest that asbestos ﬁltering during commer-
cial manufacture of alcoholic drinks probably continued into the
late 1970s.13
In 1973, when one of the authors (JMR) was a house surgeon
in London, a middle-aged male patient was admitted to have a
ﬁngertip amputated for a Bowen’s tumour (squamous cell
carcinoma-in-situ) of the nail-bed. The patient acknowledged
that he was exposed to asbestos in his occupation as a publican
(landlord/manager of a British public house (“pub”) or bar). He
explained that it was common practice to take the “slops” (the
beer that had splashed into a bucket below the hand pump
used for serving draught beer in a typical British pub) at the end
of the day, add a slurry of asbestos and then run them through a
ﬁlter – he made a circular swishing gesture with his hand to
show how this was done. The asbestos-ﬁltered “slops” were then
served to the (presumably unsuspecting) ﬁrst customers into the
pub the next day. The patient thought this practice was quite
common at that time. It seems likely that this ﬁltration
technique, if widely used, would have given even greater
exposure to people, principally men, drinking draught beer in
British pubs during the time, perhaps decades, when this
practice was used. Thus, although commercial use of asbestos
ﬁltering in alcoholic drinks was a common practice across many
countries, the much cruder use of asbestos ﬁltration in public
houses might have given particularly high exposure to British
beer drinkers.
INGESTED ASBESTOS AS A RISK FACTOR FOR OESOPHAGEAL
ADENOCARCINOMA
Epidemiology studies have failed to show any convincing
association between alcohol consumption and the risk of
oesophageal adenocarcinoma;8 however, any association with
exposure to asbestos in alcoholic drinks, particularly beer, is likely
to have been missed. This is partly because only those people who
were adults in the 1970s or earlier would have been exposed, and
alcohol consumption during that time period would not have
been assessed in the association studies, which were not
performed until at least ten years later and usually addressed
current or recent drinking habits which are less relevant given the
lengthy lag period between asbestos exposure and cancer risk.
Moreover, asbestos exposure might be very variable depending
on the type and source of the alcohol consumed. For example, the
relatively low, but rising, risk for oesophageal adenocarcinoma
amongst African-American males14 might relate to a higher
proportion of alcohol intake from spirits rather than beers,
particularly in the 1970s when risk of asbestos contamination of
beer is likely to have been greatest.15
A 2016 meta-analysis of 20 cohort studies has shown that
occupational exposure to asbestos is associated with a moderately
increased risk of oesophageal cancer (standardised mortality ratio
(SMR) 1.24; 95% CI 1.13,1.38, P < 0.001) but did not differentiate
between adenocarcinoma and squamous cell carcinoma.16 In the
prospective Netherlands Cohort Study of 58,279 men followed
over a mean of 17.3 years, a signiﬁcant association between
occupational asbestos exposure was found for adenocarcinoma of
the oesophagus but not for squamous cell carcinoma.17 For ever
versus never highly exposed subjects, the hazard ratio (HR) for
adenocarcinoma of oesophagus was 2.52 (95%CI 1.01,6.26) with a
signiﬁcant exposure-response relationship both for duration of
exposure and cumulative exposure (P < 0.05). These results
support an earlier study from Sweden showing an incidence rate
ratio of 4.5 [95%CI 1.4,14.3] for occupational asbestos exposure
and adenocarcinoma of the oesophagus but, again, no signiﬁcant
association with squamous cell carcinoma.18
It is presumed that asbestos ﬁbres are ingested either by
contamination of food/drink or by swallowing sputum following
inhalation. It should be noted that the strength of association
between occupational asbestos exposure and oesophageal
adenocarcinoma is relatively modest compared with that for
occupational exposure and pleural mesothelioma in which odds
ratios might be as high as 50;19 it is plausible, though, that
asbestos in ﬁltered beverages, particularly beer, might have
accounted for the major source of ingested asbestos and would
have been missed by studies of oesophageal adenocarcinoma
based on occupational asbestos exposure. The latter studies
typically assess exposure to building materials such as asbestos
insulating boards, lagging or cement, or a surrogate for this such
as construction or shipyard working or carpentry. One study has
investigated the association between exposure to asbestos and
the risk of Barrett’s oesophagus, ﬁnding a possible trend that was
not signiﬁcant on multivariate analysis.20
Asbestos as a risk factor for adenocarcinoma but not squamous
cell carcinoma
It is not surprising that the oesophagus might be particularly
susceptible to the harmful effects of ingested asbestos; however, it
is less clear why ingested asbestos should be a risk factor for
adenocarcinoma but not for squamous cell cancer. A similar
increased association between asbestos exposure and adenocar-
cinoma of the lung (RR 3.31) compared with squamous cell lung
cancer (RR1.67) has also been reported.21 Possibly the ﬁne
asbestos ﬁbres are more likely to penetrate columnar epithelium
than squamous epithelium. This would then also help explain why
Barrett’s oesophagus, with its columnar epithelium, is such a
strong risk factor for oesophageal adenocarcinoma.22
One might therefore also expect ingested asbestos to be a risk
for gastric and other intestinal cancers. The prospective Nether-
lands Cohort study did indeed show associations between
prolonged exposure to high levels of asbestos and increased risks
for gastric cancer (including non-cardia gastric cancer (cancer of
the lower stomach)) as well as for colon and rectal cancer.20
Mortality rates for both gastric cancer and colorectal cancer in
Britain have, however, been steadily declining since the 1970s23
indicating that factors other than asbestos, including the
falling incidence of H. pylori and the impact of bowel cancer
screening, are likely quantitatively more important for cancer at
those sites.
Box 1 Various asbestos ﬁbres and their use in ﬁlters
Asbestos ﬁbres and ﬁlters
Asbestos comprises a group of six naturally occurring silicate minerals typiﬁed by
long ﬁbrous crystals. All are regarded as carcinogenic. As the sole, curly ﬁbred,
member of the serpentine group of asbestos, chrysotile (white asbestos)
accounts for about 90–95% of worldwide use, and probably confers a
substantially lower mesothelioma risk than members of the amphibole group
which are straight and needle-like and include amosite (brown asbestos) and
crocidolite (blue asbestos), as well as tremolite, actinolite and anthophyllite.60
The use of chrysotile for wine ﬁltration has been clearly documented61 and this
seems the most likely ﬁbre type for use in beer ﬁltration12 although the more
dangerous crocidolite was notoriously used in the manufacture of cigarette
ﬁlters.62
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Evidence for asbestos in the gastrointestinal tract
Concerns started to be raised in the 1970s about the possible
health effects of asbestos in beverages but relatively few studies
examined human intestinal samples directly for presence of
asbestos.24,25 The detection of asbestos ﬁbres ideally requires
transmission electron microscopy of concentrated residues after
digestion and ashing of tissue samples although for tissue samples
(rather than lavage ﬂuid, for example) the identiﬁcation of
asbestos bodies in tissue sections using light microscopy might
have equivalent sensitivity.26 Autopsy studies of 26 male subjects
over 40 years old showed that individuals with the highest
concentration of pulmonary asbestos bodies also had asbestos
bodies at varying concentrations particularly in the oesophagus
(mean 15.5 per gram) and to a lesser extent in the stomach (mean
1.6 per gram), small intestine (mean 1.2 per gram) and colon (1.1
per gram) as well as in other organs, particularly the spleen (mean
6.6 per gram).27 A study of patients with colorectal cancer found
asbestos ﬁbre and/or asbestos bodies at a mean concentration of
approximately 2.5 × 106 per gram in colon tissue from 14 out of 44
patients with a history of occupational asbestos exposure
compared with 0 of 20 colon cancer patients without a history
of asbestos exposure.28 No equivalent systematic analysis of
asbestos in oesophageal cancer tissue has been reported,
although in two cases–one adenocarcinoma and one squamous
cell carcinoma–asbestos bodies were found within tumour tissue
in patients with a history of occupational asbestos exposure.29
(Supplementary Fig. 1)
MECHANISMS OF ASBESTOS-INDUCED NEOPLASIA:
COMPARISONS WITH MESOTHELIOMA
The strongest tumour association with asbestos exposure is for
mesothelioma, particularly of the pleura. It is therefore worth
considering the mechanisms for asbestos carcinogenicity and
then to compare the biology of oesophageal adenocarcinoma and
pleural mesothelioma.
Asbestos as a tumour promoter rather than an initiator
Although early in vitro assays suggested that asbestos was not
genotoxic, subsequent studies by various investigators demon-
strated genotoxic effects including chromosomal aberrations such as
aneuploidy.30–32 However, the very long incubation period from
initial asbestos exposure to tumour manifestation, typically several
decades, has been taken to suggest that asbestos is acting as a
tumour promoter rather than as an initiator.30 Studies on lung cancer
tissue have shown that adenocarcinomas tend to exhibit less allelic
loss than squamous cell carcinomas and that asbestos exposure
correlates with a greater frequency of p53 mutation, which again
implies a tumour promoting effect through loss of suppression.33
In mesotheliomas, increased mutation frequency has consis-
tently been reported in tumour suppressors such as neuroﬁbro-
matosis type 2 (NF2)34,35 and the nuclear deubiquitinase Bap1.36
Monosomy of chromosome 22 or deletions in 22q that include
NF2 as well as homozygous deletions in 9p21, which encompass
the cyclin-dependent kinase inhibitor 2A (CDKN2A locus), are
reported in up to 72% cases of mesothelioma,36 but there are also
frequent deletions at other sites, including 1p, 3p, 4p, 6q, 13q, 14q,
and 15q.37 Indeed, mesothelioma is considered to be a ‘disease of
gene loss’ rather than being associated with classical driver
mutations in oncogenes,38 which is similar to the situation that
has long been appreciated for oesophageal adenocarcinoma.39 It
should be noted, however, that many of these molecular changes
also occur in epithelial cancers that do not have asbestos as a
known major factor. The inﬂammatory response to asbestos ﬁbres,
including macrophage activation and associated cytokine release,
is also thought likely to be important in tumour promotion.40
Notably, gene copy number changes are very common in
oesophageal adenocarcinoma with a large number of
chromosomal rearrangements reported.41–44 It is perhaps
not surprising that there is some overlap with the typical
chromosomal alterations found in mesothelioma such as 9p21
deletions, which have long been known to occur early
in disease pathogenesis, including in premalignant Barrett’s
oesophagus.45–47 However, in view of the heterogeneity of
oesophageal adenocarcinoma48 and the limited data sets avail-
able for mesothelioma, it is difﬁcult to make precise comparisons
with the genetic landscape of mesothelioma.
Mutational signatures
A complementary approach that has been facilitated by the
advent of whole genome sequencing is to identify and classify
mutational processes through the statistical analysis of the
frequency of base changes (A > C, T > G, etc.) throughout the
entire genome, which can also be viewed in the context of the
base either side (so-called ‘trinucleotide context’). Through the
analysis of many normal and cancer genomes, a number of
patterns or so-called ‘mutational signatures’ have been described
which can, in some cases, be ascribed to particular mutagens such
as UV radiation, cigarette smoke or physiological ageing and a
catalogue of these signatures has been compiled using a non-
negative matrix factorisation algorithm.49–51
The most frequent and speciﬁc signatures observed in oesopha-
geal adenocarcinoma are T>G substitutions in a CTT context, called
the ‘S17 signature’.41 Other signatures reﬂect ageing (S1); a complex
pattern caused by defects in the BRCA1/2-led homologous
recombination pathway (S3); C>T mutations in a TCA/TCT context,
which is due to mutations in the apolipoprotein B mRNA editing
enzyme, catalytic polypeptide-like (APOBEC) proteins (S2); and C>A/
T dominant in a GCA/TCT context (S18), which is also found in
gastric carcinoma as well as neuroblastoma. The APOBEC signature
is also associated with characteristic clusters of localised hypermuta-
tion, named kataegis, in which a single strand accumulates a high
burden of C>T and C>G mutations.43
A similarly rigorous genome-wide mutational analysis has yet to
be performed for pleural mesothelioma, although there are data
from peritoneal mesothelioma which has a weaker association
with asbestos exposure.52 These data include signature 5, a
transcriptional bias for T>C in an ApTpN context. Although this
signature is also found in oesophageal adenocarcinoma, it is
present in other cancer types, too, and its aetiology is unknown.
To identify the unknown cancer-causing factors, a study to
Box 2 Comparison of biology between pleural mesotheliomas
and oesophageal adenocarcinoma – it should be noted that
many of these changes are common in other tumours also –
better evidence for similarities in underlying aetiology might
be uncovered when patterns of nucleotide substitutions are
known for mesothelioma
Pleural mesothelioma Oesophageal adenocarcinoma
Increased mutation and deletion
frequency in tumour suppressors
Alterations in tumour suppressors
including TP53 are early events
DNA hypermethylation (including
hypermethylation of tumour
suppressors) common
Altered DNA methylation
(majority with hypermethylation)
Chromosomal alterations include
9p21 deletions
9p21 deletions occur early eg in
Barrett’s oesophagus
Pattern of nucleotide
substitutions (signatures) not
yet known
Signature nucleotide
substitutions include T > G in CTT,
C > T in TCI/TCT, C > A/T in
GCA/TCT with characteristic
clusters of localised
hypermutation (kataegis)
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sequence the genomes of 5000 cancers, including oesophageal
cancer, from across ﬁve continents is currently underway.53
Additional genome-wide sequencing data in mesothelioma are
required to allow a comparative analysis between pleural
mesothelioma and oesophageal adenocarcinoma. (Box 2)
MESOTHELIOMA PREDICTIONS AS A POSSIBLE MODEL FOR
THE FUTURE OF OESOPHAGEAL ADENOCARCINOMA
Britain has the highest rate of mesothelioma worldwide but
almost all cases relate to exposure before 1980 when asbestos was
widely used. Crocidolite use ended in 1970 and amosite use by the
late 1970s.54 Thus, of 2542 deaths from mesothelioma in 2015,
only three of the deceased were born after 1975,55 and it has been
predicted that asbestos-related mesothelioma should have
disappeared in Britain by 2055, by which time anyone born
before 1965 will be over 90.54 Given that asbestos ingestion from
beer should only affect people who had already reached
adulthood by the late 1970s, then the epidemic of oesophageal
adenocarcinoma, if related to asbestos ingestion from beer rather
than occupational exposure, might resolve slightly earlier, perhaps
by 2050, and should be reducing well before then. This scenario is
substantially more optimistic than has been predicted by
statistical analysis using age-period-cohort models,7 and is
compatible with the similar incidence trends seen for mesothe-
lioma and oesophageal adenocarcinoma (Fig. 1).
Beer will not, of course, be the only source of ingested asbestos;
it might plausibly represent the major source for some individuals
but could be a relatively less important source than occupational
asbestos exposure for other individuals. In relation to this, it is
notable that Britain sadly leads the world for mesothelioma
mortality rate, as well as for oesophageal adenocarcinoma, and
that mesothelioma also has a similar, very strong male pre-
dominance – ~4.2 to 1 in Britain,54 similar to the 4.5 to 1 ratio for
oesophageal adenocarcinoma in England.7 A broader hypothesis
would therefore be that the epidemic of oesophageal
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Fig. 1 Incidence trends for mesothelioma and oesophageal adenocarcinoma. a Age-adjusted incidence of oesophageal adenocarcinoma in
England by year of diagnosis (Modiﬁed from7: British Journal of Cancer 118, 1391–1398 (2018)). b European age-standardised mortality rates for
mesothelioma in Great Britain by year (Data from Cancer Research UK Cancer Statistics59). Note that mesothelioma data are for mortality, but
adenocarcinoma oesophagus data are for incidence; however, both conditions have an average life expectancy of around one year from
diagnosis, so the trends are approximately comparable
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adenocarcinoma might be substantially related to ingested
asbestos from all sources including both ﬁltered beers and
occupational exposure. A recent study has shown that manufac-
tured carbon nanotubes, which are similar in shape to asbestos
ﬁbres, and are widely used in sports equipment, computers and
building, might also induce mesothelioma with similar latencies
and molecular pathways to asbestos, including early loss of p16/
lnk4a, suggesting that other modern manufacturing materials
should also be examined for their potential carcinogenicity.56
CONCLUSIONS AND FURTHER STUDIES
It seems plausible that ingested asbestos ﬁbres – particularly, but
not solely, from beer consumed before 1980 - could be a
signiﬁcant factor in the epidemic of oesophageal adenocarcinoma
that has particularly affected males in selected countries. The key
points supporting this association are summarised in Box 3. If this
hypothesis is correct, then there should be a substantial fall in
incidence, hopefully culminating in a return to a low background
level by ~ 2050 in the UK. Other countries may have differing
incidence trajectories depending on when - and whether – the use
of asbestos ﬁltration in brewing has been abandoned.57 Indeed,
different countries have different time trends for incidence of
oesophageal carcinoma58 but it is hard to know whether or not
these differing time trends relate to differing asbestos exposure.
Useful circumstantial supportive evidence might be obtainable
from further comparative studies of the molecular alterations in
oesophageal adenocarcinoma and pleural mesothelioma, and by
further analysis of oesophageal tumour tissue for evidence of
asbestos.
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Box 3 Key Points: Asbestos ingestion as an explanation for the
epidemic of oesophageal adenocarcinoma
•Widespread usage of asbestos ﬁltering in brewing and manufacture of alcoholic
drinks prior to 1980.
•Uncontrolled usage of asbestos ﬁltering of draught beer in British public houses.
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